Autres langues Terns Pharmaceuticals, Inc.

Actions

TERN

US8808811074

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 06/05/2024			Varia. 5j.	Varia. 1 janv.
5,79 ^USD	+6,43%		+13,53%	-10,79%

29/04	Terns Pharmaceuticals, Inc. annonce les résultats de l'étude pharmacocinétique de phase 1 en cours sur l'inhibiteur allostérique de BCR-ABL Tern-701 chez des volontaires adultes en bonne santé et met en évidence le potentiel de différenciation concurrentielle de ce produit	CI
10/04	Terns Pharmaceuticals, Inc. nomme Melita Sun Jung au poste de Chief Business Officer	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(4)	06/05
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)	03/05
Terns Pharmaceuticals : Corporate Presentation April 2024	29/04
Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation	29/04
Terns Pharmaceuticals, Inc. Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor Tern-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation	29/04
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer	10/04
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer	10/04
Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer	10/04
North American Morning Briefing : Stocks Struggle After New Records	22/03
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates	14/03
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	14/03
Thinking about buying stock in Marathon Digital, Assertio, Ocean Biomedical, Terns Pharmaceuticals, or NextCure?	12/03
Terns Pharmaceuticals Gets Orphan Drug Label for Chronic Myeloid Leukemia Treatment Candidate	11/03
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia	11/03
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(4)	08/03
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)	07/03
Terns Pharmaceuticals : Corporate Presentation March 2024	04/03
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences	27/02
TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANTS TO NEW CHIEF EXECUTIVE OFFICER UNDER NASDAQ LISTING RULE 5635(4)	08/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Terns Pharmaceuticals, Inc.

Actions

TERN

US8808811074

Autres langues

Filtres